Ron Bentsur - Jun 30, 2022 Form 4 Insider Report for Beyond Air, Inc. (XAIR)

Role: Director
Signature: /s/ Ron Bentsur
Stock symbol: XAIR
Transactions as of: Jun 30, 2022
Transactions value $: -$261,104
Form type: 4
Date filed: 7/5/2022, 04:44 PM
Previous filing: Jun 30, 2022
Next filing: Aug 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XAIR	Common Stock	Sale	-$261K	-40K	-21.93%	$6.53	142K	Jun 30, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale was made to satisfy an Israeli tax obligation resulting from the reporting person's ownership of shares of Advanced Inhalation Therapies (AIT) Ltd., an Israeli corporation, which merged with Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.), a Delaware corporation, on January 13, 2017.
F2	The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.50 to $6.57, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

Content

The sale was made to satisfy an Israeli tax obligation resulting from the reporting person's ownership of shares of Advanced Inhalation Therapies (AIT) Ltd., an Israeli corporation, which merged with Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.), a Delaware corporation, on January 13, 2017.

The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.50 to $6.57, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.